Literature DB >> 21965125

Changes in hemodynamic parameters and cerebral saturation during supraventricular tachycardia.

Jared A Hershenson1, Pamela S Ro, Yongjie Miao, Joseph D Tobias, Vincent Olshove, Aymen N Naguib.   

Abstract

Induced supraventricular tachycardia (SVT) during electrophysiology studies (EPS) can be associated with hemodynamic changes. Traditionally, invasive arterial blood pressure has been used for continuous monitoring of these changes. This prospective study evaluated the efficacy of near-infrared spectroscopy (NIRS) monitoring during SVT. The use of NIRS has expanded with evidence of its accuracy and benefit in detecting cerebral hypoperfusion. This study aimed first to determine the hemodynamic changes associated with electrophysiology testing for SVT and second to determine whether the hemodynamic changes are associated with similar changes in the cerebral saturation as determined by NIRS. The study enrolled 30 patients 5-20 years of age with a history of SVT who underwent an EPS. The demographic data included age, gender, weight, height, and type of SVT. Hemodynamic data (invasive blood pressure and heart rate), NIRS, bispectral index (BIS), end-tidal carbon dioxide, and pulse oximetry were collected before and during three episodes of induced SVT. The linear correlation coefficient (r) was measured to calculate the relationship of the changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) to the changes in NIRS values during the SVT episodes. Data from 22 patients were collected. The induction of SVT was associated mainly with a change in SBP and a less prominent change in DBP and MAP from baseline. The changes in hemodynamic status were associated with minimal changes in cerebral saturations, as evidenced by an average absolute change in NIRS of <1 from baseline value. The changes in hemodynamics were correlated linearly with cerebral saturation. Changes in SBP, DBP, and MAP were correlated positively with changes in NIRS, as denoted by (r) values of 0.52, 0.57, and 0.67 respectively, and a P value less than 0.05 for all three association tests. Induction of SVT during electrophysiology testing is associated with hemodynamic changes, mainly in SBP. In this study, these hemodynamic changes resulted in a minimal decrease in cerebral perfusion, as evidenced by minimal changes in the cerebral saturation measured by NIRS (0.7% from baseline). Although the changes in the cerebral saturation were minimal, these changes were linearly correlated with the changes in the hemodynamics. This study is the first to demonstrate the possible application of NIRS monitoring during EPS and to document that despite changes in the hemodynamic status, the changes in cerebral oxygenation are minimal, thereby confirming the safety of EPS for SVT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965125     DOI: 10.1007/s00246-011-0133-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

1.  Syncope and supraventricular tachycardia.

Authors:  V Kühlkamp; R Bosch; C Mewis
Journal:  Circulation       Date:  2001-11-13       Impact factor: 29.690

2.  Changes in near-infrared spectroscopy and the bispectral index during tilt-table examination.

Authors:  Aymen N Naguib; Peter Winch; Pamela S Ro; Vincent Olshove; Joseph D Tobias
Journal:  Pediatr Cardiol       Date:  2011-01-06       Impact factor: 1.655

3.  Acute blood pressure effects at the onset of supraventricular and ventricular tachycardia.

Authors:  Taresh Taneja; Alan H Kadish; Michele A Parker; Jeffrey J Goldberger
Journal:  Am J Cardiol       Date:  2002-12-15       Impact factor: 2.778

4.  Cerebrovascular reacivity assessment in patients with carotid artery disease: a combined TCD and NIRS study.

Authors:  Spyros N Vasdekis; Georgios Tsivgoulis; Dimitrios Athanasiadis; Athina Andrikopoulou; Konstantinos Voumvourakis; Andreas M Lazaris; Elefterios Stamboulis
Journal:  J Neuroimaging       Date:  2011-03-29       Impact factor: 2.486

5.  Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry.

Authors:  J D Kugler; D A Danford; K Houston; G Felix
Journal:  Am J Cardiol       Date:  1997-12-01       Impact factor: 2.778

6.  Electrophysiologic and haemodynamic correlates in supraventricular tachycardia.

Authors:  P Sganzerla; F Fabbiocchi; S Grazi; C Cipolla; P Moruzzi; M D Guazzi
Journal:  Eur Heart J       Date:  1989-01       Impact factor: 29.983

7.  Cerebral hemodynamics during induced tachycardia in routine electrophysiologic studies: a transcranial Doppler study.

Authors:  P Zunker; C Haase; M Borggrefe; D Georgiadis; A Georgiadis; E B Ringelstein
Journal:  Neurol Res       Date:  1998-09       Impact factor: 2.448

8.  The hemodynamic effects of induced supraventricular tachycardia in man.

Authors:  B N Goldreyer; J A Kastor; K L Kershbaum
Journal:  Circulation       Date:  1976-11       Impact factor: 29.690

9.  Hemodynamic changes induced by supraventricular tachycardia.

Authors:  A Mobilij; E D'Annunzio; L Paloscia; G Volpi; G D'Orazio; G Rasetti; P Zambelli; G Nafra; M Valloreo
Journal:  G Ital Cardiol       Date:  1982

10.  Influence of ventriculoatrial timing on hemodynamics and symptoms during supraventricular tachycardia.

Authors:  Gabriel Laurent; Howard Leong-Poi; Iqwal Mangat; Victoria Korley; Arnold Pinter; Xudong Hu; Petsy Pui-Sze So; Andrew Ramadeen; Paul Dorian
Journal:  J Cardiovasc Electrophysiol       Date:  2008-09-03
View more
  2 in total

1.  Propofol effect on cerebral oxygenation in children with congenital heart disease.

Authors:  Thilo Fleck; Stephan Schubert; Peter Ewert; Brigitte Stiller; Nicole Nagdyman; Felix Berger
Journal:  Pediatr Cardiol       Date:  2014-10-14       Impact factor: 1.655

Review 2.  Cerebral near-infrared spectroscopy in the care of patients during cardiological procedures: a summary of the clinical evidence.

Authors:  Annelies Moerman; Frederik Meert; Stefan De Hert
Journal:  J Clin Monit Comput       Date:  2015-10-08       Impact factor: 2.502

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.